Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 267

Results For "care"

4404 News Found

European Commission approves Keytruda plus Trastuzumab and chemotherapy as first-line treatment for GEJ
Drug Approval | August 30, 2023

European Commission approves Keytruda plus Trastuzumab and chemotherapy as first-line treatment for GEJ

KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population


BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint
Clinical Trials | August 29, 2023

BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint

Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year


Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation
People | August 29, 2023

Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation

Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer


Thermo Fisher Scientific launches ‘Made in India’ TSV Series lab refrigerators and freezers
Medical Device | August 29, 2023

Thermo Fisher Scientific launches ‘Made in India’ TSV Series lab refrigerators and freezers

The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions


Global Hospitals Parel Mumbai completes 100 successful robotic surgeries
Medical Device | August 29, 2023

Global Hospitals Parel Mumbai completes 100 successful robotic surgeries

The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology


Zydus to present on ZYIL1 at the International Congress of Parkinson's Disease and Movement Disorders
Clinical Trials | August 28, 2023

Zydus to present on ZYIL1 at the International Congress of Parkinson's Disease and Movement Disorders

In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers


Lynparza plus abi/pred approved in Japan for treatment of prostate cancer
Drug Approval | August 25, 2023

Lynparza plus abi/pred approved in Japan for treatment of prostate cancer

First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent


India’s MRI systems market to reach $950 million by 2030, forecasts GlobalData
News | August 25, 2023

India’s MRI systems market to reach $950 million by 2030, forecasts GlobalData

India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023


Vice President Jagdeep Dhankar delivers convocation address at the 48th AIIMS convocation
News | August 24, 2023

Vice President Jagdeep Dhankar delivers convocation address at the 48th AIIMS convocation

Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country


First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl
Policy | August 24, 2023

First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl

Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl